SWK Holdings Corporation (SWKH) stock surged +0.83%, trading at $17.05 on NASDAQ, up from the previous close of $16.91. The stock opened at $17.02, fluctuating between $16.89 and $17.13 in the recent session.
| Filing Date | Accepted Date | |
|---|---|---|
| Filing Date | Accepted Date | |
|---|---|---|
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Mar 17, 2026 | 17.13 | 17.13 | 16.89 | 17.05 | 2.84K |
| Mar 16, 2026 | 17.00 | 17.01 | 16.75 | 16.91 | 3.3K |
| Mar 13, 2026 | 16.65 | 17.17 | 16.65 | 17.17 | 7.8K |
| Mar 12, 2026 | 16.74 | 16.81 | 16.64 | 16.81 | 3.7K |
| Mar 11, 2026 | 16.92 | 16.92 | 16.75 | 16.75 | 2.59K |
| Mar 10, 2026 | 16.72 | 16.88 | 16.72 | 16.84 | 2.26K |
| Mar 09, 2026 | 16.73 | 16.94 | 16.73 | 16.91 | 4.05K |
| Mar 06, 2026 | 16.78 | 16.86 | 16.75 | 16.81 | 3.82K |
| Mar 03, 2026 | 16.25 | 16.45 | 16.20 | 16.40 | 5.69K |
| Mar 02, 2026 | 16.40 | 16.42 | 16.25 | 16.28 | 2.67K |
| Feb 27, 2026 | 16.74 | 16.74 | 16.42 | 16.42 | 45.31K |
| Feb 26, 2026 | 16.75 | 16.85 | 16.68 | 16.68 | 2.14K |
| Feb 25, 2026 | 16.75 | 16.75 | 16.65 | 16.65 | 2.39K |
| Feb 24, 2026 | 16.77 | 16.77 | 16.65 | 16.66 | 3.38K |
| Feb 23, 2026 | 16.65 | 16.70 | 16.65 | 16.65 | 4.67K |
| Feb 20, 2026 | 16.56 | 17.02 | 16.56 | 16.70 | 14.41K |
| Feb 19, 2026 | 16.74 | 16.77 | 16.67 | 16.67 | 4.23K |
| Feb 18, 2026 | 17.00 | 17.00 | 16.86 | 16.98 | 5.56K |
| Feb 17, 2026 | 17.13 | 17.44 | 16.82 | 17.19 | 2.23K |
| Feb 13, 2026 | 17.00 | 17.05 | 16.96 | 17.00 | 4.86K |
SWK Holdings Corporation, a specialty finance company that focuses on the healthcare sector. It operates in two segments, Finance Receivables and Pharmaceutical Development. The company provides customized financing solutions to a range of life science companies, including companies in the biotechnology, medical device, medical diagnostics and related tools, animal health, and pharmaceutical industries, as well as institutions and inventors. It also offers non-discretionary investment advisory services to institutional clients in separately managed accounts to invest in life science finance. In addition, the company engages in the pharmaceutical development, formulation and manufacturing, and licensing business through the Peptelligence platform. Further, it intends to out-license its internal product pipeline to create novel formulations using its proprietary technology to develop treatments for patients and caregivers. The company was formerly known as Kana Software, Inc. and changed its name to SWK Holdings Corporation in December 2009. SWK Holdings Corporation was founded in 1996 and is headquartered in Dallas, Texas.
| Employees | 24 |
| Beta | 0.33 |
| Sales or Revenue | $37.76M |
| 5Y Sales Change% | 0.499% |
| Fiscal Year Ends | December |
| Sector | Financial Services |
| Industry | Asset Management |
© 2026 Stocks Telegraph All rights reserved.
Most stock quote data provided by Financial Modeling Prep